Search Results - "Ntshalintshali, N."

Housing quality as a potential risk factor for locally acquired malaria infection in Swaziland by Mkhonta, N., Allen, R., Pindolia, D., Ntshalintshali, N., Novotny, J., Dufour, M. Kang, Gosling, R., LeMenach, A., Cohen, J., Midekisa, A., Greenhouse, B., Hsiang, M.S., Kunene, S.

Get full text

Nurse led, primary care based antiretroviral treatment versus hospital care: a controlled prospective study in Swaziland by Humphreys, Ciaran P, Wright, John, Walley, John, Mamvura, Canaan T, Bailey, Kerry A, Ntshalintshali, Sweetness N, West, Robert M, Philip, Aby

“…Antiretroviral treatment services delivered in hospital settings in Africa increasingly lack capacity to meet demand and are difficult to access by patients…”
Get full text

From diagnosis to case investigation for malaria elimination in Swaziland: is reporting and response timely? by Dlamini, N., Zulu, Z., Kunene, S., Geoffroy, E., Ntshalintshali, N., Owiti, P., Sikhondze, W., Makadzange, K., Zachariah, R.

“…Background: Swaziland is one of the southern African countries that aim to eliminate malaria by 2020. In 2010, the country introduced an Immediate Disease…”
Get full text

Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study by Poirot, Eugenie, Soble, Adam, Ntshalintshali, Nyasatu, Mwandemele, Asen, Mkhonta, Nomcebo, Malambe, Calisile, Vilakati, Sibonakaliso, Pan, Sisi, Darteh, Sarah, Maphalala, Gugu, Brown, Joelle, Hwang, Jimee, Pace, Cheryl, Stergachis, Andy, Vittinghoff, Eric, Kunene, Simon, Gosling, Roland

“…Countries remain reluctant to adopt the 2012 World Health Organization recommendation for single low-dose (0.25 mg/kg) primaquine (SLD PQ) for Plasmodium…”
Get full text